Your answers help personalize your next steps.
What is your main goal?
Choose the one that feels most true right now.
Your answers help personalize your next steps.
Choose the one that feels most true right now.
About This Assessment
This short eligibility assessment is designed to help you understand whether you may be a candidate for clinician-guided GLP-1 weight loss therapy through Open Water Rx. The assessment takes approximately 60 seconds to complete and asks questions about your primary health goals, weight loss objectives, previous experience with diet and exercise, familiarity with GLP-1 medications, treatment priorities, timeline, age range, and state of residence. Your answers help us personalize your next steps and match you with the most appropriate program option.
This assessment is not a medical diagnosis. It is a preliminary screening tool only and does not establish a patient-provider relationship. Final eligibility for any Open Water Rx program is always determined by an independent licensed medical provider who reviews your complete health history, current medications, and individual circumstances. The assessment cannot guarantee that you will qualify for treatment, nor can it predict your individual results. Compounded GLP-1 medications are not FDA-approved finished drug products.
Open Water Rx serves patients in all 50 states through telehealth. Some states require a brief synchronous video visit with a licensed provider before a prescription can be issued. If you complete this assessment and appear to be a candidate for treatment, you will be directed to complete a full 5-minute online health evaluation reviewed by a licensed medical provider. There is no cost to take this assessment, and you are under no obligation to proceed with treatment.
Receive your preliminary eligibility result based on your answers
If you appear to qualify, complete the full 5-minute health evaluation
An independent licensed provider reviews your complete health profile
If clinically appropriate, your provider issues a personalized treatment plan
Medication ships discreetly from a licensed pharmacy if prescribed
This quiz does not constitute medical advice or establish a patient-provider relationship
Final eligibility is determined solely by an independent licensed medical provider
Compounded GLP-1 medications are not FDA-approved finished drug products
Individual results vary significantly based on adherence, biology, and lifestyle
Treatment is prescribed only when a provider determines clinical appropriateness
Open Water Rx does not manufacture, compound, or dispense medications
Some states require a synchronous video visit before initial prescribing
All patient data is handled in accordance with HIPAA privacy regulations
GLP-1 (glucagon-like peptide-1) receptor agonists are prescription medications that have transformed the landscape of chronic weight management. Semaglutide, a GLP-1 receptor agonist, produced an average of 15 to 17 percent body weight reduction in the landmark STEP 1 clinical trial published in the New England Journal of Medicine. Tirzepatide, a dual GIP and GLP-1 receptor agonist, achieved up to 22.5 percent average body weight loss in the SURMOUNT-1 trial — the highest efficacy ever recorded in a pharmaceutical weight loss study.
These medications work by mimicking natural gut hormones that signal fullness to the brain, slowing gastric emptying, reducing appetite at the neurological level, and helping regulate blood sugar. They are not over-the-counter supplements or diet pills. They are prescription-only medications that require clinical oversight. Through Open Water Rx, eligible patients receive compounded semaglutide or tirzepatide prescribed by an independent licensed provider, with medication prepared by a licensed, FDA-registered compounding pharmacy and shipped discreetly to their door.
Clinical trial averages do not guarantee individual results. Factors including adherence to the prescribed protocol, starting weight, biological response, concurrent medications, and lifestyle habits all influence outcomes. Your licensed provider will discuss realistic expectations based on your specific health profile during your clinical review.